ABSTRACT: O-benzyl-L-serine carboxyanhydrides were synthesized via diazotization of O-benzyl-L-serine with sodium nitrite in sulfuric acid aqueous solution followed by cyclization of the resulting serine-based α-hydroxy acid with phosgene. Degradable, water-soluble poly(α-hydroxy acids) bearing pendant hydroxyl groups were readily prepared under mild conditions via ring-opening polymerization of O-benzyl-L-serine carboxyanhydrides followed by the removal of the benzyl group and showed excellent cell compatibility, suggesting their potential being used as novel materials in constructing drug delivery systems and as hydrogel scaffolds for tissue engineering applications.
P oly(α-hydroxy acids) (PAHAs), such as poly(lactic acid) (PLA), poly(glycolic acid), and poly(lactic-co-glycolic acid), are widely used in controlled release, drug delivery, and tissue engineering because of their excellent biocompatibility and biodegradability.
1 One drawback of conventional PAHAs is their lack of side-chain functionalities, which has prevented structural alteration via side-chain modifications and thus limited PAHA applications, particularly in situations requiring postmodification of PAHA side chains. Over the past decades, tremendous effort has been devoted to the development of side-chain functionalized PAHAs via the introduction of pendant functional groups to modulate the physicochemical and biological properties of PAHAs, 2 in particular via the synthesis and polymerization of various substituted 1,4-dioxane-2,5-diones or morpholine-2,5-diones. 2o,3,4 However, the approach and the level of difficulty for the synthesis of these monomers vary from case to case. It would be of great interest to develop a general strategy for the synthesis of PAHAs with a variety of pendant functional groups.
Ring-opening polymerization (ROP) of O-carboxyanhydrides (OCAs), 5 a class of five-membered ring compounds derived from amino acids, has recently emerged as a viable method to prepare side-chain functionalized PAHAs. 3b,6 OCAs were found to have excellent polymerization activities; the ROP of lactide-OCA (Lac-OCA, derived from alanine, Scheme 1) in the presence of 4-dimethylaminopyridine (DMAP) finished in hours and afforded PLA with controlled molecular weights in quantitative yields. In conjunction with our efforts of developing PLA-based nanomedicines, 7 we have been interested in utilizing ROP of OCAs to synthesize a class of hydrophilic PAHAs for drug delivery applications. Most of the prior work on ROP of OCAs has focused on developing hydrophilic, charged polymers. 2r,5c However, when used in vivo, charged, hydrophilic polymers tend to show nonspecific tissue interaction and reduced circulation half-lives. Hydrophilic, noncharged polymers are often more useful materials in drug delivery, exemplified by polyethylene glycol 8 and cyclodextrin-based polymers. 9 In this study, we report the design and synthesis of Ser-PAHA, a class of noncharged, water-soluble PAHA with pendant hydroxy groups, via the living ROP of O-benzyl-L-serine carboxyanhydrides (Ser(Bn)-OCA), a new OCA monomer derived from serine (Scheme 1). The functionalized monomer Ser(Bn)-OCA was prepared via diazotization of O-benzyl-L-serine with sodium nitrite in sulfuric acid aqueous solution followed by cyclization of the resulting serine-based α-hydroxy acid with phosgene (Scheme 1). Recrystallization from diisopropyl ether and dichloromethane (DCM) afforded grams to tens of grams of colorless crystalline Ser(Bn)-OCA in ∼50% yield. The ROP of Ser(Bn)-OCA was evaluated with DMAP as the catalyst and isobutanol (IB) as the initiator at various monomer-to-initiator (M/I) ratios in DCM ( Figure 1a ) under conditions similar to those reported by Bourissou and co-workers.
5a DMAP/IB showed remarkable control for the ROP of Ser(Bn)-OCA and gave Ser(Bn)-PAHA with the expected molecular weights (MWs) and very narrow molecular weight distributions (MWDs, around 1.05−1.15) over a broad range of M/I ratios (50−800; Figure 1a ). The M n values of Ser(Bn)-PAHA at M/I ratios of 50 and 800 were 9.4 × 10 3 g/mol and 1.41 × 10 5 g/mol (entries 1−2, Table 1 We also investigated the DMAP-catalyzed ROP of Ser(Bn)-OCA with other initiators. DMAP/pyrenemethanol (Pyr) in DCM solution gave similarly well-controlled polymerization (entries 3−4, Table 1 ). The polymerizations mediated by DMAP/ Pyr in tetrahydrofuran (THF) and toluene also gave Ser(Bn)-PAHAs with the expected MWs, although the polydispersity indices of the Ser(Bn)-PAHAs obtained in THF were slightly higher than those obtained in toluene (entries 5−8, Table 1 ). When methoxy-poly(ethylene glycol) (mPEG) was used as the initiator, mPEG-Ser(Bn)-PAHA copolymers were obtained with the expected MWs and low polydispersity indexes (entries 9−10, Table 1 ).
M n was linearly correlated with monomer conversion throughout the polymerization, suggesting that the ROP of Ser(Bn)-OCA with DMAP as catalyst might have proceeded in a living fashion (Figure 1d ). To further study if this was a living polymerization, we sequentially added Ser(Bn)-OCA monomers during polymerization. The first block of Ser(Bn)-PAHA had a monomodal GPC curve, an M n of 1.95 × 10 4 g/mol, and an M w /M n of 1.15 at a Ser(Bn)-OCA/IB/DMAP ratio of 100:1:1. The subsequent addition of a second portion of 100 equiv of Ser(Bn)-OCA afforded Ser(Bn)-PAHA with a wellmaintained monomodal GPC curve that was shifted toward higher MWs compared to the MW observed for the first block; M n was 3.81 × 10 4 g/mol, and M w /M n was 1.09. We also The pendant benzyl ether groups of Ser(Bn)-PAHA were removed via catalytic hydrogenolysis under hydrogen in THF/ methanol (3:1 v/v) for 24 h in the presence of Degussa-type Pd/C catalyst (30% w/w relative to the polymer, Scheme 1). 1 H NMR analysis of the deprotected polymer (Ser-PAHA) showed no detectable aromatic signals at 7.2 ppm, indicating the complete removal of the benzyl group. Pd/C mediated deprotection of polyester side chains is known to be mild enough that it does not lead to the degradation of polyester backbones even at elevated temperatures.
5d After hydrogenolysis, a 50-mer Ser(Bn)-PAHA with an M n value of 11.6 × 10 3 g/mol resulted in a deprotected polymer Ser-PAHA with an M n value of 6.3 × 10 3 g/mol ( Figure S7 of the Supporting Information), which is in excellent agreement with the expected M n (5.7 × 10 3 g/mol). To further evaluate whether the catalytic hydrogenolysis condition has a deleterious effect on PAHA, we went on to treat the Ser-PAHA for an additional 24 h in the identical conditions used for deprotection. No degradation was observed based on GPC analysis of the further treated Ser-PAHA ( Figure S7 ). Another strong evidence of successful deprotection of side chain benzyl group of Ser(Bn)-PAHA is the drastically changed solvent solubility of Ser(Bn)-PAHA. Ser(Bn)-PAHA is very soluble in THF but is insoluble in water or methanol. However, Ser-PAHA, the deprotected polymer, shows completely opposite solubility in those solvents; it is highly soluble in water and methanol but insoluble in THF.
The cytotoxicity of Ser-PAHA was evaluated in HeLa cells using the MTT assay. Ser-PAHA showed no cytotoxicity (p > 0.05 vs the control) at concentrations up to 200 μg/mL (60 μM) following both short-term (4 h) and long-term (24 h) incubation (Figure 2a) . To demonstrate the utility of this new water-soluble material, we prepared a Ser-PAHA-coated surface by spin coating and found that HeLa cells adhered strongly to the surface with no difference with the control (Figure 2b) .
Given the broad interest of PAHA and other related degradable 10 and hydroxyl-containing, water-soluble polymers, Experimental section, NMR spectra, and GPC results for all compounds tested. This material is available free of charge via the Internet at http://pubs.acs.org.
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